AVITA Medical, Inc. (RCEL)
NASDAQ: RCEL · IEX Real-Time Price · USD
8.55
-0.09 (-1.04%)
At close: Apr 22, 2024, 4:00 PM
8.60
+0.05 (0.58%)
After-hours: Apr 22, 2024, 7:09 PM EDT

AVITA Medical Statistics

Total Valuation

AVITA Medical has a market cap or net worth of $219.79 million. The enterprise value is $189.07 million.

Market Cap 219.79M
Enterprise Value 189.07M

Important Dates

The next confirmed earnings date is Monday, May 13, 2024, after market close.

Earnings Date May 13, 2024
Ex-Dividend Date n/a

Share Statistics

AVITA Medical has 25.71 million shares outstanding.

Shares Outstanding 25.71M
Owned by Insiders (%) 0.66%
Owned by Institutions (%) 28.08%
Float 24.81M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 4.26
Forward PS 2.85
PB Ratio 6.93
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 3.67
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 7.88, with a Debt / Equity ratio of 0.85.

Current Ratio 7.88
Quick Ratio 7.33
Debt / Equity 0.85
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -29.90

Financial Efficiency

Return on equity (ROE) is -54.80% and return on invested capital (ROIC) is -47.10%.

Return on Equity (ROE) -54.80%
Return on Assets (ROA) -38.10%
Return on Capital (ROIC) -47.10%
Revenue Per Employee $249,135
Profits Per Employee -$170,923
Employee Count 207
Asset Turnover 0.56
Inventory Turnover 2.02

Taxes

In the past 12 months, AVITA Medical has paid $42,647 in taxes.

Income Tax 42,647
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -40.13% in the last 52 weeks. The beta is 1.29, so AVITA Medical's price volatility has been higher than the market average.

Beta (1Y) 1.29
52-Week Price Change -40.13%
50-Day Moving Average 15.45
200-Day Moving Average 14.62
Relative Strength Index (RSI) 15.22
Average Volume (30 Days) 224,722

Short Selling Information

Short Interest 726,204
Short Previous Month 590,733
Short % of Shares Out 2.84%
Short % of Float n/a
Short Ratio (days to cover) 3.95

Income Statement

In the last 12 months, AVITA Medical had revenue of $51.57 million and -$35.38 million in losses. Loss per share was -$0.90.

Revenue 51.57M
Gross Profit 28.30M
Operating Income -27.56M
Pretax Income -22.82M
Net Income -35.38M
EBITDA -21.19M
EBIT -22.08M
Loss Per Share -$0.90
Full Income Statement

Balance Sheet

The company has $57.55 million in cash and $26.82 million in debt, giving a net cash position of $30.72 million or $1.20 per share.

Cash & Cash Equivalents 57.55M
Total Debt 26.82M
Net Cash 30.72M
Net Cash Per Share $1.20
Equity / Book Value 31.70M
Book Value Per Share 1.23
Working Capital 58.68M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$24.56 million and capital expenditures -$892,353, giving a free cash flow of -$25.45 million.

Operating Cash Flow -24.56M
Capital Expenditures -892,353
Free Cash Flow -25.45M
FCF Per Share -$1.00
Full Cash Flow Statement

Margins

Gross margin is 54.87%, with operating and profit margins of -53.45% and -68.61%.

Gross Margin 54.87%
Operating Margin -53.45%
Pretax Margin -44.25%
Profit Margin -68.61%
EBITDA Margin -41.09%
EBIT Margin -42.82%
FCF Margin -49.36%

Dividends & Yields

AVITA Medical does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -1.32%
Shareholder Yield -1.32%
Earnings Yield -16.10%
FCF Yield -11.58%

Analyst Forecast

The average price target for AVITA Medical is $28.25, which is 230.41% higher than the current price. The consensus rating is "Strong Buy".

Price Target $28.25
Price Target Difference 230.41%
Analyst Consensus Strong Buy
Analyst Count 5
Revenue Growth Forecast (5Y) 27.95%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

The last stock split was on June 30, 2020. It was a reverse split with a ratio of 1:5.

Last Split Date Jun 30, 2020
Split Type Reverse
Split Ratio 1:5

Scores

AVITA Medical has an Altman Z-Score of 0.24 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score 0.24
Piotroski F-Score 3